CVE-2025-61940 (GCVE-0-2025-61940)
Vulnerability from cvelistv5
Published
2025-12-02 21:07
Modified
2025-12-02 21:39
Severity ?
8.7 (High) - CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N
8.3 (High) - CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
8.3 (High) - CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
VLAI Severity ?
EPSS score ?
CWE
Summary
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
References
Impacted products
| Vendor | Product | Version | ||
|---|---|---|---|---|
| Mirion Medical | EC2 Software NMIS BioDose |
Version: 0 < 23.0 |
{
"containers": {
"adp": [
{
"metrics": [
{
"other": {
"content": {
"id": "CVE-2025-61940",
"options": [
{
"Exploitation": "none"
},
{
"Automatable": "no"
},
{
"Technical Impact": "partial"
}
],
"role": "CISA Coordinator",
"timestamp": "2025-12-02T21:39:17.758822Z",
"version": "2.0.3"
},
"type": "ssvc"
}
}
],
"providerMetadata": {
"dateUpdated": "2025-12-02T21:39:30.055Z",
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"shortName": "CISA-ADP"
},
"title": "CISA ADP Vulnrichment"
}
],
"cna": {
"affected": [
{
"defaultStatus": "unaffected",
"product": "EC2 Software NMIS BioDose",
"vendor": "Mirion Medical",
"versions": [
{
"lessThan": "23.0",
"status": "affected",
"version": "0",
"versionType": "custom"
},
{
"status": "unaffected",
"version": "23.0"
}
]
}
],
"credits": [
{
"lang": "en",
"type": "finder",
"value": "Joe Dillon reported these vulnerabilities to Mirion Medical."
}
],
"datePublic": "2025-12-02T17:00:00.000Z",
"descriptions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eNMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\u003c/span\u003e\n\n\u003c/span\u003e\n\n\u003c/span\u003e"
}
],
"value": "NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection."
}
],
"metrics": [
{
"cvssV4_0": {
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"attackVector": "NETWORK",
"baseScore": 8.7,
"baseSeverity": "HIGH",
"exploitMaturity": "NOT_DEFINED",
"privilegesRequired": "LOW",
"providerUrgency": "NOT_DEFINED",
"subAvailabilityImpact": "NONE",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"userInteraction": "NONE",
"valueDensity": "NOT_DEFINED",
"vectorString": "CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N",
"version": "4.0",
"vulnAvailabilityImpact": "LOW",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnerabilityResponseEffort": "NOT_DEFINED"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
},
{
"cvssV3_1": {
"attackComplexity": "LOW",
"attackVector": "NETWORK",
"availabilityImpact": "LOW",
"baseScore": 8.3,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "LOW",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L",
"version": "3.1"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
}
],
"problemTypes": [
{
"descriptions": [
{
"cweId": "CWE-603",
"description": "CWE-603",
"lang": "en",
"type": "CWE"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2025-12-02T21:07:47.995Z",
"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"shortName": "icscert"
},
"references": [
{
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01"
}
],
"solutions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eMirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact \u003c/span\u003e\u003ca target=\"_blank\" rel=\"nofollow\"\u003eMirion Medical support\u003c/a\u003e\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\u0026nbsp;directly.\u003c/span\u003e\n\n\u003cbr\u003e"
}
],
"value": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support\u00a0directly."
}
],
"source": {
"advisory": "ICSMA-25-336-01",
"discovery": "EXTERNAL"
},
"title": "Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication",
"x_generator": {
"engine": "Vulnogram 0.5.0"
}
}
},
"cveMetadata": {
"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"assignerShortName": "icscert",
"cveId": "CVE-2025-61940",
"datePublished": "2025-12-02T21:07:47.995Z",
"dateReserved": "2025-11-11T20:56:52.843Z",
"dateUpdated": "2025-12-02T21:39:30.055Z",
"state": "PUBLISHED"
},
"dataType": "CVE_RECORD",
"dataVersion": "5.2",
"vulnerability-lookup:meta": {
"nvd": "{\"cve\":{\"id\":\"CVE-2025-61940\",\"sourceIdentifier\":\"ics-cert@hq.dhs.gov\",\"published\":\"2025-12-02T21:15:51.930\",\"lastModified\":\"2025-12-04T17:15:08.283\",\"vulnStatus\":\"Awaiting Analysis\",\"cveTags\":[],\"descriptions\":[{\"lang\":\"en\",\"value\":\"NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\"}],\"metrics\":{\"cvssMetricV40\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Secondary\",\"cvssData\":{\"version\":\"4.0\",\"vectorString\":\"CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X\",\"baseScore\":8.7,\"baseSeverity\":\"HIGH\",\"attackVector\":\"NETWORK\",\"attackComplexity\":\"LOW\",\"attackRequirements\":\"NONE\",\"privilegesRequired\":\"LOW\",\"userInteraction\":\"NONE\",\"vulnConfidentialityImpact\":\"HIGH\",\"vulnIntegrityImpact\":\"HIGH\",\"vulnAvailabilityImpact\":\"LOW\",\"subConfidentialityImpact\":\"NONE\",\"subIntegrityImpact\":\"NONE\",\"subAvailabilityImpact\":\"NONE\",\"exploitMaturity\":\"NOT_DEFINED\",\"confidentialityRequirement\":\"NOT_DEFINED\",\"integrityRequirement\":\"NOT_DEFINED\",\"availabilityRequirement\":\"NOT_DEFINED\",\"modifiedAttackVector\":\"NOT_DEFINED\",\"modifiedAttackComplexity\":\"NOT_DEFINED\",\"modifiedAttackRequirements\":\"NOT_DEFINED\",\"modifiedPrivilegesRequired\":\"NOT_DEFINED\",\"modifiedUserInteraction\":\"NOT_DEFINED\",\"modifiedVulnConfidentialityImpact\":\"NOT_DEFINED\",\"modifiedVulnIntegrityImpact\":\"NOT_DEFINED\",\"modifiedVulnAvailabilityImpact\":\"NOT_DEFINED\",\"modifiedSubConfidentialityImpact\":\"NOT_DEFINED\",\"modifiedSubIntegrityImpact\":\"NOT_DEFINED\",\"modifiedSubAvailabilityImpact\":\"NOT_DEFINED\",\"Safety\":\"NOT_DEFINED\",\"Automatable\":\"NOT_DEFINED\",\"Recovery\":\"NOT_DEFINED\",\"valueDensity\":\"NOT_DEFINED\",\"vulnerabilityResponseEffort\":\"NOT_DEFINED\",\"providerUrgency\":\"NOT_DEFINED\"}}],\"cvssMetricV31\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Secondary\",\"cvssData\":{\"version\":\"3.1\",\"vectorString\":\"CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L\",\"baseScore\":8.3,\"baseSeverity\":\"HIGH\",\"attackVector\":\"NETWORK\",\"attackComplexity\":\"LOW\",\"privilegesRequired\":\"LOW\",\"userInteraction\":\"NONE\",\"scope\":\"UNCHANGED\",\"confidentialityImpact\":\"HIGH\",\"integrityImpact\":\"HIGH\",\"availabilityImpact\":\"LOW\"},\"exploitabilityScore\":2.8,\"impactScore\":5.5}]},\"weaknesses\":[{\"source\":\"ics-cert@hq.dhs.gov\",\"type\":\"Primary\",\"description\":[{\"lang\":\"en\",\"value\":\"CWE-603\"}]}],\"references\":[{\"url\":\"https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01\",\"source\":\"ics-cert@hq.dhs.gov\"}]}}",
"vulnrichment": {
"containers": "{\"adp\": [{\"title\": \"CISA ADP Vulnrichment\", \"metrics\": [{\"other\": {\"type\": \"ssvc\", \"content\": {\"id\": \"CVE-2025-61940\", \"role\": \"CISA Coordinator\", \"options\": [{\"Exploitation\": \"none\"}, {\"Automatable\": \"no\"}, {\"Technical Impact\": \"partial\"}], \"version\": \"2.0.3\", \"timestamp\": \"2025-12-02T21:39:17.758822Z\"}}}], \"providerMetadata\": {\"orgId\": \"134c704f-9b21-4f2e-91b3-4a467353bcc0\", \"shortName\": \"CISA-ADP\", \"dateUpdated\": \"2025-12-02T21:39:24.460Z\"}}], \"cna\": {\"title\": \"Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication\", \"source\": {\"advisory\": \"ICSMA-25-336-01\", \"discovery\": \"EXTERNAL\"}, \"credits\": [{\"lang\": \"en\", \"type\": \"finder\", \"value\": \"Joe Dillon reported these vulnerabilities to Mirion Medical.\"}], \"metrics\": [{\"format\": \"CVSS\", \"cvssV4_0\": {\"Safety\": \"NOT_DEFINED\", \"version\": \"4.0\", \"Recovery\": \"NOT_DEFINED\", \"baseScore\": 8.7, \"Automatable\": \"NOT_DEFINED\", \"attackVector\": \"NETWORK\", \"baseSeverity\": \"HIGH\", \"valueDensity\": \"NOT_DEFINED\", \"vectorString\": \"CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N\", \"exploitMaturity\": \"NOT_DEFINED\", \"providerUrgency\": \"NOT_DEFINED\", \"userInteraction\": \"NONE\", \"attackComplexity\": \"LOW\", \"attackRequirements\": \"NONE\", \"privilegesRequired\": \"LOW\", \"subIntegrityImpact\": \"NONE\", \"vulnIntegrityImpact\": \"HIGH\", \"subAvailabilityImpact\": \"NONE\", \"vulnAvailabilityImpact\": \"LOW\", \"subConfidentialityImpact\": \"NONE\", \"vulnConfidentialityImpact\": \"HIGH\", \"vulnerabilityResponseEffort\": \"NOT_DEFINED\"}, \"scenarios\": [{\"lang\": \"en\", \"value\": \"GENERAL\"}]}, {\"format\": \"CVSS\", \"cvssV3_1\": {\"scope\": \"UNCHANGED\", \"version\": \"3.1\", \"baseScore\": 8.3, \"attackVector\": \"NETWORK\", \"baseSeverity\": \"HIGH\", \"vectorString\": \"CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L\", \"integrityImpact\": \"HIGH\", \"userInteraction\": \"NONE\", \"attackComplexity\": \"LOW\", \"availabilityImpact\": \"LOW\", \"privilegesRequired\": \"LOW\", \"confidentialityImpact\": \"HIGH\"}, \"scenarios\": [{\"lang\": \"en\", \"value\": \"GENERAL\"}]}], \"affected\": [{\"vendor\": \"Mirion Medical\", \"product\": \"EC2 Software NMIS BioDose\", \"versions\": [{\"status\": \"affected\", \"version\": \"0\", \"lessThan\": \"23.0\", \"versionType\": \"custom\"}, {\"status\": \"unaffected\", \"version\": \"23.0\"}], \"defaultStatus\": \"unaffected\"}], \"solutions\": [{\"lang\": \"en\", \"value\": \"Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support\\u00a0directly.\", \"supportingMedia\": [{\"type\": \"text/html\", \"value\": \"\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003eMirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact \u003c/span\u003e\u003ca target=\\\"_blank\\\" rel=\\\"nofollow\\\"\u003eMirion Medical support\u003c/a\u003e\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003e\u0026nbsp;directly.\u003c/span\u003e\\n\\n\u003cbr\u003e\", \"base64\": false}]}], \"datePublic\": \"2025-12-02T17:00:00.000Z\", \"references\": [{\"url\": \"https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01\"}], \"x_generator\": {\"engine\": \"Vulnogram 0.5.0\"}, \"descriptions\": [{\"lang\": \"en\", \"value\": \"NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\", \"supportingMedia\": [{\"type\": \"text/html\", \"value\": \"\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003e\\n\\n\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003e\\n\\n\u003cspan style=\\\"background-color: rgb(255, 255, 255);\\\"\u003eNMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\u003c/span\u003e\\n\\n\u003c/span\u003e\\n\\n\u003c/span\u003e\", \"base64\": false}]}], \"problemTypes\": [{\"descriptions\": [{\"lang\": \"en\", \"type\": \"CWE\", \"cweId\": \"CWE-603\", \"description\": \"CWE-603\"}]}], \"providerMetadata\": {\"orgId\": \"7d14cffa-0d7d-4270-9dc0-52cabd5a23a6\", \"shortName\": \"icscert\", \"dateUpdated\": \"2025-12-02T21:07:47.995Z\"}}}",
"cveMetadata": "{\"cveId\": \"CVE-2025-61940\", \"state\": \"PUBLISHED\", \"dateUpdated\": \"2025-12-02T21:39:30.055Z\", \"dateReserved\": \"2025-11-11T20:56:52.843Z\", \"assignerOrgId\": \"7d14cffa-0d7d-4270-9dc0-52cabd5a23a6\", \"datePublished\": \"2025-12-02T21:07:47.995Z\", \"assignerShortName\": \"icscert\"}",
"dataType": "CVE_RECORD",
"dataVersion": "5.2"
}
}
}
Loading…
Loading…
Sightings
| Author | Source | Type | Date |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or seen somewhere by the user.
- Confirmed: The vulnerability is confirmed from an analyst perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: This vulnerability was exploited and seen by the user reporting the sighting.
- Patched: This vulnerability was successfully patched by the user reporting the sighting.
- Not exploited: This vulnerability was not exploited or seen by the user reporting the sighting.
- Not confirmed: The user expresses doubt about the veracity of the vulnerability.
- Not patched: This vulnerability was not successfully patched by the user reporting the sighting.
Loading…
Loading…